Fungal pyrrolidine-containing metabolites inhibit alkaline phosphatase activity in bone morphogenetic protein-stimulated myoblastoma cells

Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989;8:98-101. Urist, 1965, The function of fibrocartilaginous fracture callus. observations on transplants labeled with tritiated thymidine, J Bone Joint Surg Br, 47, 304, 10.1302/0301-620X.47B2.304 Gazzerro, 2006, Bone morphogenetic proteins and their antagonists, Rev Endocr Metab Disord, 7, 51, 10.1007/s11154-006-9000-6 Shi, 2003, Mechanisms of TGF-beta signaling from cell membrane to the nucleus, Cell, 113, 685, 10.1016/S0092-8674(03)00432-X Macías-Silva, 1998, Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2, J Biol Chem, 273, 25628, 10.1074/jbc.273.40.25628 Katagiri, 2002, Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis, Genes Cells, 7, 949, 10.1046/j.1365-2443.2002.00573.x Peltier L.F. A case of extraordinary exostoses on the back of a boy. 1740. John Freke (1688–1756). Clin Orthop Relat Res 1998;346:5–6. Glaser, 2003, In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification, J Bone Joint Surg Am, 85, 2332, 10.2106/00004623-200312000-00010 Kaplan, 1993, Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family, J Bone Joint Surg Am, 75, 1214, 10.2106/00004623-199308000-00011 Kaplan, 2010, Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva, J Bone Joint Surg Am, 92, 686, 10.2106/JBJS.I.00705 Connor, 1982, Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients, J Bone Joint Surg Br, 64, 76, 10.1302/0301-620X.64B1.7068725 Shore, 2006, A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva, Nat Genet, 38, 525, 10.1038/ng1783 Yu, 2008, Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism, Nat Chem Biol, 4, 33, 10.1038/nchembio.2007.54 Hao, 2010, In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors, ACS Chem Biol, 5, 245, 10.1021/cb9002865 Cuny, 2008, Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors, Bioorg Med Chem Lett, 18, 4388, 10.1016/j.bmcl.2008.06.052 Yu, 2008, BMP type I receptor inhibition reduces heterotopic [corrected] ossification, Nat Med, 14, 1363, 10.1038/nm.1888 Katagiri, 1994, Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage, J Cell Biol, 127, 1755, 10.1083/jcb.127.6.1755 Fukuda, 2008, A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor, Biochem Biophys Res Commun, 377, 905, 10.1016/j.bbrc.2008.10.093 Ohte, 2011, A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H, Biochem Biophys Res Commun, 407, 213, 10.1016/j.bbrc.2011.03.001 Fukuda, 2009, Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva, J Biol Chem, 284, 7149, 10.1074/jbc.M801681200 Kakeya, 2001, Lucilactaene, a new cell cycle inhibitor in p53-transfected cancer cells, produced by a Fusarium sp, J Antibiot, 54, 850, 10.7164/antibiotics.54.850 Bashyal, 2007, 13a-Hydroxylucilactaene and other metabolites of an endophytic strain of Fusarium acuminatum, Nat Prod Commun, 2, 547 Bashyal, 2010, Tricinonoic acid and tricindiol, two new irregular sesquiterpenes from an endophytic strain of Fusarium tricinctum, Nat Prod Res, 24, 349, 10.1080/14786410903125401 Krasnoff, 2006, Production of mutagenic metabolites by Metarhizium anisopliae, J Agric Food Chem, 54, 7083, 10.1021/jf061405r Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, Immunol Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Secondini, 2011, The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis, PLoS One, 6, e16078, 10.1371/journal.pone.0016078 Pierre, 2005, Testing the antagonistic effect of follistatin on BMP family members in ovine granulosa cells, Reprod Nutr Dev, 45, 419, 10.1051/rnd:2005031 Paulsen, 2011, Negative feedback in the bone morphogenetic protein 4 (BMP4) synexpression group governs its dynamic signaling range and canalizes development, Proc Natl Acad Sci USA, 108, 10202, 10.1073/pnas.1100179108 Yamaguchi, 2006, FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor, J Mol Endocrinol, 36, 569, 10.1677/jme.1.01966 Boergermann, 2010, Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells, Int J Biochem Cell Biol, 42, 1802, 10.1016/j.biocel.2010.07.018 Kokabu, 2011, Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase, Mol Endocrinol, 25, 474, 10.1210/me.2010-0305